evans blue has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buller, HR; Esmon, CT; Niers, TM; Richel, DJ; Spek, CA; Tigchelaar, W; Van Noorden, CJ; Van Sluis, GL | 1 |
Bjørnaes, I; Graff, BA; Rofstad, EK | 1 |
2 other study(ies) available for evans blue and B16 Melanoma
Article | Year |
---|---|
Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement.
Topics: Animals; Antibodies, Monoclonal; Anticoagulants; Antigens, CD; Cadherins; Endothelium, Vascular; Evans Blue; Female; Melanoma, Experimental; Mice; Models, Biological; Neoplasms; Oxadiazoles; Protein C; Receptors, Lysosphingolipid; Signal Transduction; Thiophenes | 2009 |
Microvascular permeability of human melanoma xenografts to macromolecules: relationships to tumor volumetric growth rate, tumor angiogenesis, and VEGF expression.
Topics: Animals; Capillary Permeability; Endothelial Growth Factors; Evans Blue; Female; Humans; Lymphokines; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Serum Albumin; Transplantation, Heterologous; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |